Notably, the number of risk alleles in PNPLA3 and GATAD2A was much higher in Matteoni type 4 (NASH) patients than in type 1, type 2, and type 3 NAFLD patients. The gene discussed is GATAD2A; the disease is metabolic dysfunction-associated steatohepatitis.